The slides were incubated with a 0.1% Picrosirius red solution and mounted with Permount Mounting Medium (Thermo Fisher Scientific)
Semaglutide results timeline Semaglutide (brand names Ozempic for diabetes, Wegovy for weight management) is a pure GLP-1 receptor agonist
Regulations and patent laws differ from country to country
Since obesity, insulin resistance, liver fat, and metabolic dysfunction are closely linked, GLP-1 and glucagon-based combinations are being studied for their potential to reduce liver fat, improve metabolic markers, and slow disease progression
This can slow or reverse fatty liver disease, which is common in people with obesity
The primary purpose of this visit was to assess compliance and record adverse events